Africa: Possible new TB drugs – after 40 year wait

An antibiotic commonly used to treat chest infections may be the world’s new weapon against tuberculosis, and the first new TB drug in 40 years. Moxifloxacin, already approved to treat severe respiratory infections, has entered the final phase of clinical trials, offering hope that a shorter course, four-drug combination could be available to cure tuberculosis (TB) by 2011.